Gemifloxacin mesylate
Cat. No.:YN251206
CAS No. :210353-53-0
产品名称: | Gemifloxacin mesylate |
CAS No.: | 210353-53-0 |
Chemical Name: | 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate |
Synonyms: | 甲磺酸吉米沙星; SB-265805S; LB-20304a |
分子量: | 485.49 |
分子式: | C₁₉H₂₄FN₅O₇S |
SMILES: | O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CC(CN)/C(C4)=N/OC)=N3)C1=O)O.CS(=O)(O)=O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Gemifloxacin mesylate 是一种口服的广谱喹诺酮类抗菌剂, 用于慢性支气管炎的急性细菌性发作, 及轻中度肺炎的研究。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Hammerschlag, M.R., Roblin, P.M., and Bébéar, C.M.Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogensJ. Antimicrob. Chemother.48(Topic T1),25-31(2001)
Ruiz-Serrano, M.J., Alcalá, L., Martínez, L., et al.In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugsAntimicrob. Agents Chemother.44(9),2567-2568(2000)
Collin, F., Karkare, S., and Maxwell, A.Exploiting bacterial DNA gyrase as a drug target: Current state and perspectivesAppl. Microbiol. Biotechnol.92(3),479-497(2011)
Weigel, L.M., Anderson, G.J., and Tenover, F.C.DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilisAntimicrob. Agents Chemother.46(8),2582-2587(2002)
Grossman, R.F., Hsueh, P.-R., Gillespie, S.H., et al.Community-acquired pneumonia and tuberculosis: Differential diagnosis and the use of fluoroquinolonesInt. J. Infect. Dis.18,14-21(2014)
Pranger, A.D., Alffenaar, J.W.C., and Aarnoutse, R.E.Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: A pharmacokinetic and pharmacodynamic approachCurr. Pharm. Des.17(27),29002-29930(2011)